Cited 0 times in
Role of adding ovarian function suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or resume menstruation after chemotherapy: The ASTRRA study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.